Thiard News@F4F

@newsen.bsky.social

2 days ago

Biotechnology Companies Making Strides in Longevity Research and Therapies Explore how biotech firms like Avaí Bio are creating revolutionary therapies through gene editing and cell-based approaches to combat aging and its effects.

Biotechnology Companies Making Strides in Longevity Research and Therapies #USA #Las_Vegas #gene_therapy #Klotho #Avaí_Bio

Thiard News@F4F

@newsen.bsky.social

3 weeks ago

Epidermolysis Bullosa Market Expected to Surge with Innovative Therapies Ahead The epidermolysis bullosa market is projected to grow significantly between 2025 and 2034, driven by rising awareness and treatment advancements.

Epidermolysis Bullosa Market Expected to Surge with Innovative Therapies Ahead #United_States #Las_Vegas #gene_therapy #Epidermolysis_Bullosa #D-Fi/FCX-007

Thiard News@F4F

@newsen.bsky.social

1 month ago

Cell and Gene Therapy Manufacturing Market Set to Soar to $146.2 Billion by 2032 The Cell and Gene Therapy Manufacturing Market is expected to grow from $19.3 billion in 2024 to $146.2 billion by 2032, driven by the demand for personalized therapies and advanced manufacturing processes.

Cell and Gene Therapy Manufacturing Market Set to Soar to $146.2 Billion by 2032 #None #gene_therapy #Cell_Therapy #Biotech_Expansion

Thiard News@F4F

@newsen.bsky.social

1 month ago

The Troubling Journey of REGENXBIO's RGX-111: A Case of Broken Promises REGENXBIO's RGX-111 gene therapy was held in high regard, but revelations about safety risks led to substantial investor losses.

The Troubling Journey of REGENXBIO's RGX-111: A Case of Broken Promises #USA #New_York #gene_therapy #REGENXBIO #RGX-111

Thiard News@F4F

@newsen.bsky.social

1 month ago

REGENXBIO Reports 2025 Financial Results and Operational Insights on Gene Therapies REGENXBIO highlights its 2025 financial performance and the ongoing advancement of its gene therapy pipeline aimed at rare diseases, notably Duchenne muscular dystrophy.

REGENXBIO Reports 2025 Financial Results and Operational Insights on Gene Therapies #USA #Rockville #gene_therapy #REGENXBIO #RGX-202

Thiard News@F4F

@newsen.bsky.social

1 month ago

BioLife Solutions Achieves Significant Revenue Growth in 2025 Financial Results BioLife Solutions reported impressive gains in its financial metrics for 2025, highlighting a strong performance in revenue and market expansion for cell and gene therapy.

BioLife Solutions Achieves Significant Revenue Growth in 2025 Financial Results #United_States #gene_therapy #Market_Expansion #BioLife_Solutions #Bothell

Thiard News@F4F

@newsen.bsky.social

1 month ago

GEMMABio Initiates Groundbreaking CHARISMA Trial for SMA1 Gene Therapy Treatment GEMMABio has initiated its pivotal CHARISMA clinical trial for GB221, a groundbreaking gene therapy targeting Spinal Muscular Atrophy Type 1, marking a significant advancement in treatment.

GEMMABio Initiates Groundbreaking CHARISMA Trial for SMA1 Gene Therapy Treatment #USA #Philadelphia #gene_therapy #GEMMABio #SMA1

Thiard News@F4F

@newsen.bsky.social

1 month ago

Viral Vectors and Plasmid DNA Manufacturing Market Projected to Surpass $34 Billion by 2033 The global market for viral vectors and plasmid DNA manufacturing is set to reach $34 billion by 2033, driven by growth in gene therapy and rising disease prevalence.

Viral Vectors and Plasmid DNA Manufacturing Market Projected to Surpass $34 Billion by 2033 #USA #gene_therapy #Portland #Plasmid_DNA #viral_vectors

Thiard News@F4F

@newsen.bsky.social

1 month ago

Hope for FRRS1L Patients: Innovative Gene Therapy Collaboration Announced Finding Hope for Frizzle and Apertura Gene Therapy have teamed up to develop a groundbreaking gene therapy targeting FRRS1L disease, raising hopes for affected children.

Hope for FRRS1L Patients: Innovative Gene Therapy Collaboration Announced #USA #gene_therapy #Fort_Collins #Apertura_Gene_Therapy #FRRS1L

Thiard News@F4F

@newsen.bsky.social

2 months ago

Global Regenerative Medicine Market Projected to Surpass $531.7 Billion by 2033 Amidst Rapid Growth The regenerative medicine market, valued at $32.1 billion in 2023, is set to expand to $531.7 billion by 2033 at a CAGR of 32.4%, fueled by chronic diseases and an aging population.

Global Regenerative Medicine Market Projected to Surpass $531.7 Billion by 2033 Amidst Rapid Growth #None #gene_therapy #regenerative_medicine #Cell_Therapy

Thiard News@F4F

@newsen.bsky.social

2 months ago

Slingshot Biosciences Expands Operations to Europe for Enhanced Therapeutic Development Slingshot Biosciences is rapidly expanding into the UK and EU markets, enhancing access to synthetic cell mimic technology for faster therapeutic development.

Slingshot Biosciences Expands Operations to Europe for Enhanced Therapeutic Development #United_Kingdom #gene_therapy #Emeryville #Slingshot_Biosciences #synthetic_cells

Thiard News@F4F

@newsen.bsky.social

2 months ago

ZipBio Partners with MeiraGTx to Propel Gene Therapy Advancements ZipBio has entered into an exclusive licensing agreement with MeiraGTx to develop innovative gene therapies for Geographic Atrophy, leveraging AI technologies for breakthroughs in treatment.

ZipBio Partners with MeiraGTx to Propel Gene Therapy Advancements #USA #Boston #gene_therapy #ZipBio #MeiraGTx

Thiard News@F4F

@newsen.bsky.social

2 months ago

NanoMosaic Achieves FDA AMT Designation for Next-Gen Gene Therapy Analytics NanoMosaic has received the FDA's Advanced Manufacturing Technology designation for its innovative Nanoneedle technology, enhancing gene therapy production.

NanoMosaic Achieves FDA AMT Designation for Next-Gen Gene Therapy Analytics #USA #FDA_Approval #gene_therapy #Waltham #Nanomosaic

Thiard News@F4F

@newsen.bsky.social

2 months ago

Genezen and Atsena Therapeutics Forge Strategic Partnership in Gene Therapy Manufacturing Genezen collaborates with Atsena to enhance gene therapy manufacturing, focusing on innovative treatments for inherited retinal diseases.

Genezen and Atsena Therapeutics Forge Strategic Partnership in Gene Therapy Manufacturing #USA #gene_therapy #Lexington,_Massachusetts #Genezen #Atsena_Therapeutics

Thiard News@F4F

@newsen.bsky.social

2 months ago

Belief BioMed Celebrates FDA IND Acceptance for AskBio's Gene Therapy Aimed at Pompe Disease Treatment Belief BioMed proudly announces AskBio's FDA IND acceptance for AB-1009, a gene therapy for late-onset Pompe disease, marking a vital milestone.

Belief BioMed Celebrates FDA IND Acceptance for AskBio's Gene Therapy Aimed at Pompe Disease Treatment #Shanghai #USA #gene_therapy #Belief_BioMed #AskBio

Thiard News@F4F

@newsen.bsky.social

3 months ago

Avista Therapeutics Unveils Groundbreaking AI Tools for Gene Therapy Advancement Avista Therapeutics has launched innovative AI-driven platforms to enhance gene therapy delivery, aiming to overcome key challenges in the medical field.

Avista Therapeutics Unveils Groundbreaking AI Tools for Gene Therapy Advancement #USA #Pittsburgh #gene_therapy #AI_Expansion #Avista_Therapeutics

Thiard News@F4F

@newsen.bsky.social

3 months ago

Innovative Partnership to Propel Development of Rare Disease Gene Therapies The ASGCT and Orphan Therapeutics Accelerator unite to enhance the commercialization of gene therapies for rare diseases, utilizing AI advancements.

Innovative Partnership to Propel Development of Rare Disease Gene Therapies #United_States #gene_therapy #Milwaukee #ASGCT #Orphan_Therapeutics

Thiard News@F4F

@newsen.bsky.social

3 months ago

STRM.BIO Secures $8 Million in Seed Funding to Enhance Gene Therapy Innovations STRM.BIO has raised $8 million in Series Seed 2 funding to further develop its non-viral gene delivery platform, enhancing gene therapy options.

STRM.BIO Secures $8 Million in Seed Funding to Enhance Gene Therapy Innovations #United_States #Cambridge #gene_therapy #biotechnology #STRM.BIO

Thiard News@F4F

@newsen.bsky.social

3 months ago

Exploring the Growth of Gene Therapy and Its Impact on Biotech Firms The gene therapy sector is poised to reach $36.55 billion by 2032. Learn how biotech companies are positioning for this lucrative market and their breakthroughs.

Exploring the Growth of Gene Therapy and Its Impact on Biotech Firms #Canada #Vancouver #gene_therapy #Avant_Technologies #Vertex_Pharmaceuticals

Thiard News@F4F

@newsen.bsky.social

3 months ago

Cell and Gene Therapy Market Poised for US$105B Growth by 2033 The cell and gene therapy market, valued at US$13.90 billion in 2024, is set to exceed US$105 billion by 2033, driven by innovation and regulatory support.

Cell and Gene Therapy Market Poised for US$105B Growth by 2033 #None #biopharmaceuticals #gene_therapy #Cell_Therapy

Thiard News@F4F

@newsen.bsky.social

3 months ago

Beyond Celiac Investments Supports RheumaGen in Celiac Disease Treatment Innovations Beyond Celiac Investments has announced vital funding for RheumaGen to develop innovative treatments for celiac disease, focusing on gene editing technologies.

Beyond Celiac Investments Supports RheumaGen in Celiac Disease Treatment Innovations #USA #Philadelphia #gene_therapy #RheumaGen #Celiac_Disease

Thiard News@F4F

@newsen.bsky.social

3 months ago

RheumaGen Secures Funding from Beyond Celiac Investments to Enhance Celiac Disease Treatments RheumaGen has announced a significant funding agreement with Beyond Celiac Investments to advance innovative treatments for celiac disease through its gene therapy platform.

RheumaGen Secures Funding from Beyond Celiac Investments to Enhance Celiac Disease Treatments #United_States #gene_therapy #Aurora #RheumaGen #Celiac_Disease

Thiard News@F4F

@newsen.bsky.social

3 months ago

Minaris and Cell and Gene Therapy Catapult Team Up to Innovate Delivery Systems for Cell and Gene Therapies Minaris and Cell and Gene Therapy Catapult have announced a collaboration aimed at enhancing delivery methods for cell and gene therapies, fostering improved manufacturing and innovation.

Minaris and Cell and Gene Therapy Catapult Team Up to Innovate Delivery Systems for Cell and Gene Therapies #USA #Philadelphia #gene_therapy #Minaris #CGT_Catapult

Thiard News@F4F

@newsen.bsky.social

3 months ago

Minaris Collaborates with Cell and Gene Therapy Catapult to Enhance Gene Therapy Delivery Technologies Minaris partners with the Cell and Gene Therapy Catapult to advance gene therapy delivery methods, improving manufacturing quality and reducing costs.

Minaris Collaborates with Cell and Gene Therapy Catapult to Enhance Gene Therapy Delivery Technologies #USA #London #gene_therapy #Minaris #CGT_Catapult

Thiard News@F4F

@newsen.bsky.social

3 months ago

The Future of Gene Therapies for Cardiomyopathies: Market Insights and Innovations from 2025 to 2034 The gene therapies for cardiomyopathies market is on the brink of significant growth, with innovative treatments emerging. This article explores advancements and forecasts for 2025-2034.

The Future of Gene Therapies for Cardiomyopathies: Market Insights and Innovations from 2025 to 2034 #None #gene_therapy #Cardiomyopathy #Lexeo_Therapeutics

Thiard News@F4F

@newsen.bsky.social

4 months ago

Breaking Boundaries: Innovations in Gene Therapies for Rare Diseases Explore the transformative world of gene therapies and mRNA platforms in addressing hard-to-treat conditions. Discover emerging biotech firms making waves.

Breaking Boundaries: Innovations in Gene Therapies for Rare Diseases #United_States #Vancouver #gene_therapy #Avant_Technologies #mRNA_Platforms

Thiard News@F4F

@newsen.bsky.social

4 months ago

Eli Lilly Completes Acquisition of Adverum Biotechnologies Following Tender Offer Eli Lilly and Adverum Biotechnologies have finalized the acquisition process, marking a significant milestone in advancing gene therapy for age-related conditions.

Eli Lilly Completes Acquisition of Adverum Biotechnologies Following Tender Offer #United_States #Indianapolis #gene_therapy #Eli_Lilly #Adverum

Thiard News@F4F

@newsen.bsky.social

4 months ago

Innovative Research Enhances Understanding and Treatment of Sickle Cell Disease Recent findings from the American Society of Hematology highlight important developments in the treatment and management of sickle cell disease, providing new hope.

Innovative Research Enhances Understanding and Treatment of Sickle Cell Disease #United_States #Orlando #gene_therapy #sickle_cell_disease #Hydroxyurea

Thiard News@F4F

@newsen.bsky.social

4 months ago

Forecasts Show Hemophilia A Market Growth Driven by New Treatments and Rising Cases The Hemophilia A market is set to grow at a CAGR of 2.9% through 2034, fueled by increasing hemophilia cases and new treatment innovations.

Forecasts Show Hemophilia A Market Growth Driven by New Treatments and Rising Cases #gene_therapy #無し #Market_Insights #Hemophilia_A

Thiard News@F4F

@newsen.bsky.social

4 months ago

STRM.BIO Receives ARPA-H Funding to Enhance Cell and Gene Therapy Innovations STRM.BIO secures funding from ARPA-H to advance its innovative megakaryocyte-derived vesicle platform for cutting-edge cell engineering therapies.

STRM.BIO Receives ARPA-H Funding to Enhance Cell and Gene Therapy Innovations #United_States #Cambridge #gene_therapy #ARPA-H #STRM.BIO